## ||||||Page| |---|---|---|---|---|---| |Trustees
and|advisors||||| |Trustees'
report|||||2-11| |Independent|Auditor's||report||| |Consolidated|statement||of financial|activities|16| |Balance sheet|||||17| |Consolidated|statement||of cash flows||18| |Notes to the financial||statements|||| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||N
v
0
I|N
N
0
N|W||LA
Ch
h
M
ID
00|COo
IDo
GO|CI
QI|GO
At||Ifl
GO
h|(h
GO
lfl|Pl
Pl
CO|0o
GO||lfl
M
lfl|o
00
ho||Ct
0|| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||||||ID|||CO||Pl||h||||h||QI|| |||14
Ct
V
I
~V
N4i
IC'|0
'00
V|W||(h
IA
Ch|||LA
Pl
QI||I|0
QI
QI
QI|CI
Ql
QI
QI|IA
ID
Pl
lfl||o
Pl
CO|IA0
IA
Ch|IU
0
J3
fg
10
ID
ftl
Vl|Gt0
T3
Cl
fll0
UN|| |||||||||||||||||||gl|10|| |||'0
Cl
V
I4t|gl
'0|W||ID
Yl
IA
N|PI
COo
IDo|GO
GQ|(II0
LA
M||LA
00
ID|lfl
Qf
0|Yl
CI
CO
hPl|QI
Ch
ID
M
Ql||lflo
ID
Ql|o
Pl
Yl|0
C
fg|N
L|| |||ID|||||CO||||||GO|GQ||||||| |0o0
(0||Ci
Ia||||IA|||||M|Pl|||||h|f
IU
0
N|8C|| |Ci
Ct0.
&C
Ci
13
C(0||N
Vv
0
I|M
(4
0
N|W||ID
ID
CO
YI
00|QI
Ch
lflo|QI
QI
(h|QI
LA
00
Olo||(0
IA
'ID
LA
m|Pi
LA
CO
lfi|ID
Ifl
IA
CQ
m
Ch|||QIo
CQ
ho
h|PI
o
CI
(h|gtN
0
I-0
NC
fg
Ol
10
CI
VI|Gt
E(0
0K
N
C
Ct
E
(DJJ|| |Ci
E00C||10
~v|N
D
C|tll||h
(h
GQ
IA|||Pl
At
Ch
p
OQ
IA||I|CI|ID
CI|h
CO
m
ID||LA
CI
U1
Ch
fft|CO
Yl
CO
Ift|Ol0
U
Ec
ID|fg
fg
UC
fgC|| |Ci
(0||Cl||||||||||||||||00|(C
ID|| |0
N
8
CO
C
13|||ID
'00|tll||QI
GQ
CO
Ch|d(Jl
Ch
lflo
PI||ID
m
fft
m||GO
IA
ID
IA
Pl|QI
ID
(h
M|CI
IA
IA
Qf
f|ID
nt
LA
M
tg||CI
M
Yl|CI
Mo
QI
IA
CO|gfI-
Ct
gfI-
Ct|V-0
fg
CL
IgI-
Cg|| |0C||||||||||||||||||N
Gt|Cl
C|| |GO
Oi
0
(O|||Ci
~V0Z||||||||GQ|GO
h||I
Ci
Cl||||Ufg
OlC
L|I-0
lf-|| |(00C
(QC
V-0
C
Oi
E
Ct
Vi
Ci
Oi
0
ID
00|CI
0
fg
Pl
13
GI'0
C
GI
gl
CI
CI
0
LL||||E0
I
Ct
E0VC|NC0
tgC00
13
fg
N
C
lg
U|N
Ct
U
Ig
ChL
'Cl
fg
I
f
Cl
0|I-fL
OI
E
N
IU
C|0
E0
0
lg
0I-|C0
Ct
0
y
0
0.
III|N
0
C
0
OI
.N
fg|fh
CI
U
fg
(0
Zl
Ig
fg
C|Cl
I
'Dc
4i
CL
4(
N
0I-|0
I0
N'0
C
a
0
Ci
E
0
E
VJSZ|N
C
0
C
0
lg
V0
0
Ct
IL|p
lg
0
V-
OI
0
D
N
Dl
C
LL|'0
lg
0
V'0S
I
I
lgV
N8V0
lg
lg
Cl'0
C
II|C0
U
E0I-
V-
13
ID
I-
ID
13
C
IU
IDD
(D
fg
N
N
Gl|C0
Vl
IU
0C
CII
C
C
fg
CL
E0UU
gf|N
C
(U
E
N
fg
UC
tgC| ## |||||Group|Group|Charity|| |---|---|---|---|---|---|---|---| ||||Notes|2023|2022|2023|2022| ||||||6||f| |Fixed assets|||||||| |Intangible|assets||13|164,651|257,542|139,330|230,066| |Tangible assets|||14|146,284|184,622|146,284|184,622| |Investments|||15|||3|3| |||||310,935|442,164|285,617|414,691| |Current assets|||||||| |Debtors|||16|2,485,802|1,315,836|2,125,556|3,391,175| |Short term|deposits|||10,618,710|8,604,156|10,618,710|8,604,156| |Cash at bank and||in hand||4,166,084|4,004,427|1,300,546|943,951| |||||17,270,596|13,924,419|14,044,812|12,939,282| |Creditors:|amounts||||||| |falling due|within|one year|17|(8,574,119)|(6,958,774)|(5,323,017)|(5,450,997)| |Net current assets||||8,696,477|6,965,645|8,721,795|7,488,285| |Total net assets||||9,007,412|7,407,809|9,007,412|7,902,976| |Funds|||19||||| |Restricted|funds|||458,382|294,505|458,382|294,505| |Unrestricted|funds|||8,549,030|7,113,304|8,549,030|7,608,471| |Funds||||9,007,412|7,407,809|9,007,412|7,902,976| ## |||||Notes|2023f|2022f| |---|---|---|---|---|---|---| |Cash flows from operating
activities:||||||| |Net cash provided|by operating|activities||24|2,017,611|1,010,510| |Cash flows from investing
activities:||||||| |Interest
income|||||194,299|2,940| |Purchase
of tangible|and intangible|fixed assets|||(35,700)|(224,562)| |Net cash (used in)|investing
activities||||(158,599)|(221,622)| |Change
in cash and|cash equivalents|in the|year||2,176,211|788,888| |Cash and cash equivalents
at the beginning|||ofthe year|25|12,608,583|11,819,695| |Total cash and cash equivalents||at the|end ofthe|||| |year||||25|14,784,794|12,608,583| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||Unrestricted|Restricted|Restricted|Total|Unrestricted|Restricted|Total| |---|---|---|---|---|---|---|---| ||fundsf||funds
f|2023f|fundsf|funds
6|2022
E| |Gifts|5,433,598|1,581,977||7,015,575|5,424,724|941,259|6,365,983| |Legacies|1,111,000|||1,111,000|||| |Donated|||||||| |services|605,291|||605,291|497,812||497,812| |Total|7,149,889|1,581,977||8,731,866|5,922,536|941,259|6,863,795| |3 Income|earned from trading||activities||||| ||Unrestricted|Restricted||Total|Unrestricted|Restricted|Total| ||funds||funds|2023|funds|funds|2022| ||f||f||f|f|f| |Corporate|||||||| |sponsorship|||||||| |and|||||||| |promotions|199,793|||199,793|148,533||148,533| |Events|1,855,201|||1,855I201|1,657,549||1,657,549| |Total|2,054,994|||2,054,994|1,806,082||1,806,082| ## ## ## ||||||||2023f|2022
E| |---|---|---|---|---|---|---|---|---| |Core grants:||||||||| |- Maternal|and Fetal Research
Unit, St Mary's|||Hospital,||Manchester|500,000|458,000| |- Tommy's|National
Centre for Miscarriage
Research||||||500,000|500,000| |- Tommy's|National
Centre for Maternity|Improvement|||||500,000|500,000| |—Tommy's|National
Centre for Preterm|Birth Research|||||421,000|| |- Bio bank,|Royal Infirmary,
Edinburgh|||||||20,000| |- Bio bank,|StThomas'
Hospital,
London|||||||20,000| |- Previous|years grants (not fully taken|up)/exceeded|||||16,914|(567,574)| ||||||||1,937,914|930,426| |Non-core|grants:|||||||| |- Fetal monitoring
vest research, St Mary's|||Hospital,||Manchester||18,908|| |—PARROT|study, StThomas'
Hospital,
London||||||30,722|122,640| |—Ursodeoxycholic
acid research, St Thomas'||||Hospital,||London||100,000| |- Diabetes|Fellowship
Clinic, StThomas'|Hospital,
London||||||59,272| |- DCMS Tampon Tax Fund Miscarriage
Tool,
Centre for Maternity
Improvement|||Tommy's||National||324,026|59,606| |Other research costs|||||||23,625|7,236| ||||||||2,335,195|1,279,180| |Outstanding|grants at 1st April 2022||||||2I817,064|3,333,360| |Grants awarded
during the year|||||||1,937,914|930,426| |Paid during|the year||||||(1,994,998)|(1,446,722)| |Outstanding|grants at 31 March 2023 falling|||due within||one year|2,759,980|2,817,064| ## |6 Expenditure
on education,
information,|and policy|2023f|2022f| |---|---|---|---| |Pregnancy
accreditation
General
health
information
provision||273,814
426,168|131,638
290,033| |Midwife pregnancy
helpline
Public relations,
cause awareness
and campaigns||77,622
596,544|104,808
855,332| |Policy
Website and tech development||292,235
481,123|150,614
409,125| |Supporter
e-newsletter
and channels
Advertising
and media||239,592
739,696|118,001
600,686| |||3,126,794|2,660,237| ## |Analysis|ofexpendit|ure||||| |---|---|---|---|---|---|---| ||||||Allocated|| ||||||support a|| ||||Staff costsf|Direct
costsf|governance
costsf|Total
2023f| |Cost of raising funds
Donations
and legacies|||673,185|698,114|260,416|1,631,715| |Corporate
and events|sponsorship,|promotions|601,211|1,101,025|231,863|1,934,099| ||||1,274,396|1,799,139|492,279|3,565,814| |Charitable
expenditure
Medical research|||336,926|2,262,368|89,655|2,688,949| |Education,|information|and policy|1,225,391|1,422,361|479,041|3,126,793| ||||1,562,317|3,684,729|568,696|5,815,742| |Total|||2,836,713|5,483,868|1,060,975|9,381,556| ## |nalysis o|fexpenditure|
—previous|year|||| |---|---|---|---|---|---|---| ||||||Allocated|| ||||||support a|| ||||Staff costsf|Direct
costsf|governance
costs
f.|Total
2022| |Cost of raising funds
Donations
and legacies|||526,113|1,144,234|266I933|1937 280| |Corporate
and events|sponsorship,|promotions|480,868|1,071,583|227,121|1,779,572| ||||1,006,981|2,215,817|494,054|3,716,852| |Charitable|expenditure|||||| |Medical research|||139,937|1,264,362|51,355|1,455,654| |Education,|information|and policy|1,041,469|1,169,520|449,248|2,660,237| ||||1,181,406|2,433,882|500,603|4,115,891| |Total|||2,188,387|4,649,699|994,657|7,832,743| ## |Analysis|of allocated s|upport
and gove|rnance
costs|||| |---|---|---|---|---|---|---| |||||Office||| |||Information
technologyf|Human
resources
f.|operating
costsf|Governance
costsf|Total
2023f| |Cost of raising funds
Donations
and legacies||61,263|23,080|167,017|9,056|260,416| |Corporate
promotions|sponsorship,
and events|54,546|20,549|148,705|8,063|231,863| |||115,809|43,629|315,722|17,119|492,279| |Charitable
expenditure
Medical
research||21,091|7,946|57,500|3,118|89,655| |Education,|information|||||| |and policy||112,695|42,455|307,233|16,658|479,041| |||133,786|50,401|364,733|19,776|568,696| |Total||249,595|94,030|680,455|36,895|1,060,975| ## |nalysis o|fallocated sup|port
and govern|ance costs-|previous ye|ar|| |---|---|---|---|---|---|---| |||||Office||| |||Information|Human|operating|Governance|Total| |||technology
f.|resources|costs|costs|2022f| |Cost of raising funds
Donations
and legacies||62,234|32,211|163,538|8,950|266,933| |Corporate
promotions|sponsorship,
and events|52,952|27,407|139,147|7,615|227,121| |||115,186|59,618|302,685|16,565|494,054| |Charitable|expenditure|||||| |Medical research||11,973|6,197|31,463|1,722|51,355| |Education,|information|||||| |and policy||104,740|54,212|275,234|15,062|449,248| |||116,713|60,409|306,697|16,784|500,603| |Total||231,899|120,027|609,382|33,349|994,657| ## |Net income|Net income||| |---|---|---|---| |Net income
is stated after charging:||2023f|2022| |Auditor's
remuneration|||| |- audit fees||30,950|27,440| |- under accrual of prior year's audit fees||180|280| |- non-audit
fees||8,906|5,080| |Depreciation
and amortisation|charge|166,929|153,716| |Operating
lease rentals||231,515|304,692| ## |0
Group staff costs|||| |---|---|---|---| |||2023|2022| |||E|E| |Salaries and wages||2,363,088|1,773,347| |Social security costs||247,077|150,681| |Pension costs||99,555|79,923| |Temporary
staff and volunteer|costs|126,993|184,435| |||2,836,713|2,188,386| ||||||2023|2022| |---|---|---|---|---|---|---| ||||||Number|Number| |Within|the|range|of|E130,000 to E139,999||1| |Within|the|range|of|E120,000 to E129,999||| |Within|the|range|of|E80,000 to E89,999||| |Within|the|range|of|E70,000 to E79,999||| |Within|the|range|of|E60,000 to E69,999||| |he average||weekly|number
of p|ersons
employed
during
the|year by department
was:|| |---|---|---|---|---|---|---| ||||||2023|2022| ||||||Number|Number| |Charitable|activities||||25|16| |Cost of generating|||funds||26|22| |Management||and administration||ofthe Charity|9|8| ||||||60|46| ## ## |||||||||||2023f|2022f| |---|---|---|---|---|---|---|---|---|---|---|---| |-|Less|than|one|year||||||120,352|35,668| |-|More|than|one|year|and|less|than|five|years|361,055|| |-|More|than|one|year|and|less|than|five|years|28,027|| |||||||||||509,434|35,668| |13
Intangible|fixed assets||| |---|---|---|---| |Software and website||Groupf|Charity
f| |Cost|||| |1 April 2022||391,152|332,624| |Additions||15,000|| |Disposals||(2,085)|(2,085)| |31March 2023||404,067|330,539| |Depreciation|||| |1 April 2022||133,610|102,558| |Charge for the year||107,891|90,736| |Disposals||(2,085)|(2,085)| |31March 2023||239,416|191,209| |Net book value|||| |1 April 2022||257,542|230,066| |31 March 2023||164,651|139,330| ## |14
Tangible fixed assets||| |---|---|---| |Office equipment|Groupf|Charityf| |Cost||| |1 April 2022|435,412|435,412| |Additions|20,700|20,700| |Disposals|(136,036)|(136,036)| |31March 2023|320,076|320,076| |Depreciation||| |1 April 2022|250,790|250,790| |Charge for the year|59,038|59,038| |Disposals|(136,036)|(136,036)| |31March 2023|173,792|173,792| |Net book value||| |1 April 2022|184,622|184,622| |31March 2023|146,284|146,284| ## |||||Grou||Chari|| |---|---|---|---|---|---|---|---| |||||2023
f|2022f|2023f|2022f| |Trade debtors||||341,507|126,135|251,637|2,625| |Taxation
recoverable||||23,775|13,803|23,775|13,803| |Amounts
owed by subsidiary|||companies|||838,422|2,434,802| |Prepayments|and accrued|income||2,120,496|1,175,898|1,011,698|939,945| |Other debtors||||24||24|| |||||2,485,802|1,315,836|2,125,556|3,391,175| ## |17
Creditors:|17
Creditors:|amounts|amounts|falling due|within one year|within one year||| |---|---|---|---|---|---|---|---|---| ||||||Grou||Chari|| ||||||2023f|2022
f|2023f|2022f| |Trade creditors|||||1,193,373|875,285|562,826|1,169,506| |VAT payable|||||10,195|10,876|10,196|10,876| |Medical|grants outstanding||||2,759,980|2,817,064|2,759,980|2,817,064| |Deferred|income||||4(316,708|2,676,360|1,099,705|887,881| |Accruals|and other creditors||||293,863|579,189|890,311|565,670| ||||||8,574,119|6,958,774|5,323,018|5,450,997| |Deferred|income|at 1st|April|2022|2,676,360|2,186,803|887,881|1,022,066| |Amount|released|to income||in the year|(2,676,360)|(2,048,594)|(887,881)|(1,022,066)| |Income|received|during|the|year|12,653,890|9,162,374|9,493,342|7,044,087| |Amount|released|to income||in the year|(8,337,182)|(6,624,223)|(8,393,637)|(6,156,206)| |Deferred|income|at 31|March 2023||4,316,708|2,676,360|1,099,705|887,881| ## |||Balance||||Balance| |---|---|---|---|---|---|---| |||31March|||Allocated|31March| |||2022|Income|Expenditure|interest|2023| |||E|E|E|6|E| |nrestricted f||||||| |General
funds||7,113,304|9,204,883|(7,957,510)|188,353|8,549,030| |Maternal
and Fetal|Research|||||| |Unit, Manchester||94,262|189,455|(177,474)|3,098|109,341| |UKRI Early Career
Researcher,
Manchester|||243,405|(113,917)||129,488| |Maternal
and Fetal|Research|||||| |Unit, Edinburgh||||||| |Maternal
and Fetal|Research|||||| |Unit, London|||30,722|(30,722)||| |National
Centre for||||||| |Miscarriage
Research||175,238|151,391|(305,120)|2,451|23,960| |UKRI Early Career||||||| |Researc he r, Nati
on aI Centre
for Miscarriage
Research|||165,014|||165,014| |National
Centre for||||||| |Maternity
Improvement||15,003|125,000|(140,000)|196|199| |UKRI Early Career||||||| |Researcher,
National
Centre||||||| |for Maternity
Improvement|||30,000|(15,122)||14,878| |DCMS Tampon Tax|Fund,|||||| |National
Centre for|Maternity|||||| |Improvement|||324,026|(324,026)||| |Tommy's
National|Centre for|||||| |Preterm
Birth Research||10,002|5,300||201|15,503| |Information
Services|||46,300|(46,300)||| |DHSC VCSE Health|and|||||| |Wellbeing
Alliance|||97,000|(97,000)||| |DHSC VCSE Health|and|||||| |Wellbeing
Alliance|Priority|||||| |Project|||12,960|(12,960)||| |UKRI HappyMums|||3,497|(3,497)||| |DHSC VCSE Health|and|||||| |Wellbeing
Fund - Pregnancy||||||| |and Parenting
at Work for
SMEs|||145,913|(145,913)||| |Scottish Executive|||11,994|(11,994)||| |Total restricted
funds||294,505|1,581,977|(1,424,046)|5,946|458,382| |Total funds||7,407,809|10,786,860|(9,381,556)|194,299|9,007,412| ## ## ## |and
treating
depression
in
pregnancy
to
i
outcomes. "|and
treating
depression
in
pregnancy
to
i
outcomes. "|and
treating
depression
in
pregnancy
to
i
outcomes. "|and
treating
depression
in
pregnancy
to
i
outcomes. "|and
treating
depression
in
pregnancy
to
i
outcomes. "|mprove
mot|hers'
and
offsp|ring's
m|ental
health|ental
health| |---|---|---|---|---|---|---|---|---|---| |Tommy's
received one grant from the Scottish|||||Government|to develop
and|improve|miscarriage|| |care resources for families|in|Scotland.|||||||| |Consolidated
statement|of|funds||—previous year|||||| |||Balance|||||||Balance| |||31March|||||Allocated||31March| |||||2021f|Income|Expendituref|interest||2022f| |Unrestricted
funds|||||||||| |General funds||6,219,605|||7,728,618|(6,837,803)|2,884||7,113,304| |Maternal
and Fetal Research|||||||||| |Unit, Manchester||||87,275|108,039|(101,068)||16|94,262| |Maternal
and Fetal Research|||||||||| |Unit, Edinburgh|||||2,000|(2,000)|||| |Maternal
and Fetal Research|||||||||| |Unit, London|||||281,912|(281,912)|||| |National
Centre for|||||||||| |Miscarriage
Research|||||175,203|||35|175,238| |National
Centre for|||||||||| |Maternity
Improvement|||125,559||145,000|(255,559)|||15,003| |DCMS Tampon Tax Fund,|||||||||| |National
Centre for Maternity|||||||||| |Improvement|||||59,606|(59,606)|||| |Tommy's
National
Centre|for||||||||| |Preterm
Birth Research|||||10,000||||10,002| |Information
Services|||135,296||42,499|(177,795)|||| |DHSC VCSE Health
and|||||||||| |Wellbeing
Alliance|||||97,000|(97,000)|||| |DHSC VCSE Vaccine|||||||||| |Hesitancy
Project|||||20,000|(20,000)|||| |Total restricted
funds|||348,130||941,259|(994,940)||56|294,505| |Totalfunds||6,567,735|||8,669,877|(7,832,743)|2,940||7,407,809| ## ## |20
Charity statement|offunds|||||| |---|---|---|---|---|---|---| ||Balance|||||Balance| ||31|March|||Allocated|31March| |||2022
E|Income
E|Expendituref|interest
E|2023
E| |nr
ricted funds||||||| |General funds|7,608,471||7,518,258|(6,753,039)|175,340|8,549,030| |Restricted funds||||||| |Maternal
and Fetal Research||||||| |Unit, Manchester||94,262|189,455|(177,474)|3,098|109,341| |UKRI Early Career
Researcher,
Manchester|||243,405|(113,917)||129,488| |Maternal
and Fetal Research||||||| |Unit, Edinburgh||||||| |Maternal
and Fetal Research||||||| |Unit, London|||30,722|(30,722)||| |National
Centre for||||||| |Miscarriage
Research|175,238||151,391|(305,120)|2,451|23,960| |UKRI Early Career||||||| |Researcher,
National
Centre||||||| |for Miscarriage
Research|||165,014|||165,014| |National
Centre for||||||| |Maternity
Improvement||15,003|125,000|(140,000)|196|199| |UKRI Early Career||||||| |Researcher,
National
Centre||||||| |for Maternity
Improvement|||30,000|(15,122)||14,878| |DCMS Tampon Tax Fund,||||||| |National
Centre for Maternity||||||| |Improvement|||324,026|(324,026)||| |Tommy's
National
Centre||||||| |for Preterm
Birth Research||10,002|5,300||201|15,503| |Information
Services|||46,300|(46,300)||| |Di-ISC VCSE Health
and||||||| |Wellbeing
Alliance|||97,000|(97,000)||| |DHSC VCSE Health
and||||||| |Wellbeing
Alliance Priority||||||| |Project|||12,960|(12,960)||| |UKRI HappyMums|||3,497|(3,497)||| |DHSC VCSE Health
and||||||| |Wellbeing
Fund - Pregnancy||||||| |and Parenting
at Work for||||||| |SMEs|||145,913|(145,913)||| |Scottish Executive|||11,994|(11,994)||| |Total restricted
funds|294,505||1,581,977|(1,424,046)|5,946|458,382| |Total funds|7,902,976||9,100,235|(8,177,085)|181,286|9,007,412| ## ## |harity statement
offunds|—previous y|ear|||| |---|---|---|---|---|---| ||Balance||||Balance| ||31March|||Allocated|31March| ||2021
E|Incomef|Expenditure
E|interest
E|2022
E| |Unrestricted
funds|||||| |General
funds|7,128,525|6,234,278|(5,757,010)|2,678|7,608,471| |Restricted funds|||||| |Maternal
and Fetal|||||| |Research
Unit, Manchester|87,275|108,039|(101,068)|16|94,262| |Maternal
and Fetal|||||| |Research
Unit, Edinburgh||2,000|(2,000)||| |Maternal
and Fetal|||||| |Research
Unit, London||281,912|(281,912)||| |National
Centre for|||||| |Miscarriage
Research||175,203||35|175,238| |National
Centre for|||||| |Maternity
Improvement|125,559|145,000|(255,559)||15,003| |DCMS Tampon Tax Fund,|||||| |National
Centre for|||||| |Maternity
Improvement||59,606|(59,606)||| |Tommy's
National
Centre|||||| |for Preterm
Birth Research||10,000|||10,002| |Information
Services|135,296|42,499|(177,795)||| |DHSC VCSE Health
and|||||| |Wellbeing
Alliance||97,000|(97,000)||| |DHSC VCSE Vaccine|||||| |Hesitancy
Project||20,000|(20,000)||| |Total restricted
funds|348,130|941,259|(994,940)|56|294,505| |Total funds|7,476,655|7,175,537|(6,751,950)|2,734|7,902I976| ## |ehalf of Tommy's.
T
re:|he results of the subsidiary|,
which are consolidated
on a line|-by-line
basis,| |---|---|---|---| |||2023f|2022
f| |Turnover||194,795|147,014| |Cost of sales||(66,790)|(109,706)| |Gross profit||128,005|37,308| |Interest
receivable||309|80| |Administration
costs||(82,857)|(58,895)| |Profit/(Loss)
for the|year|45,457|(21,507)| |Retained earnings|||| |At 1 April 2022||(21,507)|| |Results for the year||45,457|(21,507)| |Distribution
to Tommy's||(23,950)|| |At 31 March 2023|||(21,507)| |Balance sheet|||| |Non-current
assets||12,406|23,039| |Current assets||147,734|955,098| |Current
liabilities||(160,138)|(999,642)| |Net assets|||(21,505)| |Called up share capital
Retained
earnings|||2
(21,507)| |Equity shareholders'|funds||(21,505)| ## |22
Subsidiary
company:|22
Subsidiary
company:|22
Subsidiary
company:|22
Subsidiary
company:|LLHM Limited|LLHM Limited|LLHM Limited|LLHM Limited|LLHM Limited||||||||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |The statement
of financial|||activities|||and||the||consolidated|||balance||sheet
include|the
results,| |assets
and
liabilities|of the|||Charity's|||wholly|||owned||subsidiary,|||LLHM
Limited|(a company| |registered
in England|and Wales,||||registration||||number|||10584979, registered
at Nicholas
House, 3||||| |Laurence
Pountney
Hill,||London,|||EC4R OBB),|||||which|develops||and|organises
fundraising
events||| |on behalf of Tommy's.||The|results|||of|the|subsidiary,||||which|are|consolidated
on a line-by-line||| |basis, are:||||||||||||||||| ||||||||||||||||2023
S|2022f| |Turnover||||||||||||||2,233,203||2,000,226| |Cost of sales|||||||||||||||(971,856)|(915,297)| |Gross profit|||||||||||||||1,261,347|1,084,929| |Interest
receivable|||||||||||||||12,704|126| |Administration
costs|||||||||||||||(795,506)|(649,798)| |Profit on ordinary
activities|||before taxation||||||||||||478,545|435,257| |Taxation
on ordinary|activities|||||||||||||||| |Profit for the financial||year|||||||||||||478,545|435,257| |Retained
earnings||||||||||||||||| |At 1 April 2022|||||||||||||||(473,662)|(908,919)| |Results for the year|||||||||||||||478,545|435,257| |Distribution
to Tommy's|||||||||||||||(4,883)|| |At 31 March 2023||||||||||||||||(473,662)| |Balance sheet||||||||||||||||| |Non-current
assets|||||||||||||||12,917|4,438| |Current assets|||||||||||||||3,916,465|3,235,318| |Current
liabilities||||||||||||||(3,929,381)||(3,713,417)| |Net assets/(liabilities)||||||||||||||||(473,661)| |Called
up share capital
Profit and loss account||||||||||||||||1
(473,662)| |Equity shareholders'|funds|||||||||||||||(473,661)| ## |6342,677) in respect
of fundraising
eve
Charity 6704,991(2022: 61,482,918).|6342,677) in respect
of fundraising
eve
Charity 6704,991(2022: 61,482,918).|6342,677) in respect
of fundraising
eve
Charity 6704,991(2022: 61,482,918).|nts.
As of 31st Ma|nts.
As of 31st Ma|rch
2023,
LLHM
Limit|ed
owed
the| |---|---|---|---|---|---|---| |24 Reconciliation
of net movement
in|||funds to net cash||flow from operating|activities| ||||||2023
E|2022f| |Net movement
in funds|||||1,599,603|840,074| |Add back depreciation|and amortisation||charge||166,928|153,716| |Deduct interest
income|shown|in investing||activities|(194,299)|(2,940)| |(Increase)
in debtors
Increase
in creditors|||||(1,169,966)
1,615,345|(631,714)
651,374| |Net cash provided
by operating||activities|||2,017,611|1,010,510| ## ## |5
Analysis o|fcash a|nd cash equivalents||| |---|---|---|---|---| ||||2023|2022| ||||6|| |Short term deposit|||10,618,710|8,604,156| |Cash at bank and|in hand||4,166,084|4,004,427| |Total cash and cash equivalents|||14,784,794|12,608,583| ||||2023|2022| ||||6|6| |Cash and cash equivalents||at 1 April 2022|12,608,583|11,819,695| |Movement|||2,176,211|788,888| |Cash and cash equivalents||at 31 March 2023|14,784,794|12,608,583| ## ||||Unrestricted|Restricted|Total| |---|---|---|---|---|---| ||||funds|funds|2023| |||||6|6| |Fixed|assets||310,935||310,935| |Cash|at bank and|in hand|14,326,412|458,382|14,784,794| |Other|net current|liabilities|(6,088,317)||(6,088,317)| |Total|||8,549,030|458,382|9,007,412| ## ||||Unrestricted|Restricted|Total| |---|---|---|---|---|---| ||||funds|funds|2022| ||||6|6|6| |Fixed|assets||442,164||442,164| |Cash|at bank and|in hand|12,314,078|294,505|12,608,583| |Other|net current|liabilities|(5,642,938)||(5,642,938)| |Total|||7,113,304|294,505|7,407,809| ## |7|Analysis o|f Charity net assets|between
funds||| |---|---|---|---|---|---| ||||Unrestricted|Restricted|Total| ||||fundsf|fundsf|2023f| |Fixed|assets||285,617||285,617| |Cash|at bank and|in hand|11,460,874|458,382|11,919,256| |Other|net current|liabilities|(3,197,461)||(3,197,461)| |Total|||8,549,030|458,382|9,007,412| ## ||||Unrestricted|Restricted|Total| |---|---|---|---|---|---| ||||funds
E|funds
E|2022f| |Fixed|assets||414,691||414,691| |Cash|at bank and|in hand|9,253,602|294,505|9,548,107| |Other|net current|liabilities|(2,059,822)||(2,059,822)| |Total|||7,608,471|294,505|7,902,976|